Neurothera Labs Inc. (TSXV:NTLX)

Market Cap	16.98M
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	84.90M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,500
Average Volume	8,925
Open	0.2000
Previous Close	n/a
Day's Range	0.2000 - 0.2000
52-Week Range	0.1550 - 0.2600
Beta	-0.08
RSI	52.70
Earnings Date	n/a

About Neurothera Labs

Neurothera Labs Inc. operates a clinical-stage pharmaceutical company. The company engages in the drug development programs based on THC and/or non-psychoactive CBD: SCI-110 for the treatment of Tourette syndrome, for the treatment of Alzheimer's disease and agitation; and SCI- 210 for the treatment of ASD and status epilepticus. Neurothera Labs Inc. was formerly known as Miza III Ventures Inc. The company is based in Vancouver, Canada. As of February 23, 2023, Neurothera Labs Inc. operates as a subsidiary of SciSparc Ltd.

• Industry: Shell Companies
• Sector: Financials
• CEO: Oz Adler
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: NTLX